Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56dim NK cells

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 2989-2998

  Hagberg, Niklas ^a   Theorell, Jakob ^b   Schlums, Heinrich ^b   Eloranta, Maija Leena ^a   Bryceson, Yenan T ^b   Rönnblom, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BINDING PROTEIN; CD229 ANTIGEN; CD319 ANTIGEN; CD56 ANTIGEN; EWING SARCOMA ACTIVATED TRANSCRIPT 2 PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; LYMPHOCYTE ANTIGEN; PROTEIN SHIP 1; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD; ANTIGENS, CD56; BLOTTING, WESTERN; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC;

EID: 84884222695     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301022     Document Type: Article

References (46)

1. Tsokos, G. C. 2011. Systemic lupus erythematosus. N. Engl. J. Med. 365: 2110-2121.
2. Lövgren, T., M. L. Eloranta, U. Båve, G. V. Alm, and L. Rönnblom. 2004. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50: 1861-1872.
3. Pisetsky, D. S. 2012. Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification. Scand. J. Immunol. 76: 223-228.
4. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19: 275-290.
5. Rönnblom, L., M. L. Eloranta, and G. V. Alm. 2006. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 54: 408-420.
6. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615.
7. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197: 711-723.
8. Peterson, K. S., J. F. Huang, J. Zhu, V. D'Agati, X. Liu, N. Miller, M. G. Erlander, M. R. Jackson, and R. J. Winchester. 2004. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J. Clin. Invest. 113: 1722-1733.
9. Higgs, B. W., Z. Liu, B. White, W. Zhu, W. I. White, C. Morehouse, P. Brohawn, P. A. Kiener, L. Richman, D. Fiorentino, et al. 2011. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann. Rheum. Dis. 70: 2029-2036.
10. Rönnblom, L., and M. L. Eloranta. 2013. The interferon signature in autoimmune diseases. Curr. Opin. Rheumatol. 25: 248-253.
11. Rönnblom, L. E., G. V. Alm, and K. E. Oberg. 1991. Autoimmunity after alphainterferon therapy for malignant carcinoid tumors. Ann. Intern. Med. 115: 178-183.
12. Borg, F. A., and D. A. Isenberg. 2007. Syndromes and complications of interferon therapy. Curr. Opin. Rheumatol. 19: 61-66.
13. Della Chiesa, M., C. Romagnani, A. Thiel, L. Moretta, and A. Moretta. 2006. Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 108: 3851-3858.
14. Eloranta, M. L., T. Lövgren, D. Finke, L. Mathsson, J. Rönnelid, B. Kastner, G. V. Alm, and L. Rönnblom. 2009. Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum. 60: 2418-2427.
15. Hagberg, N., O. Berggren, D. Leonard, G. Weber, Y. T. Bryceson, G. V. Alm, M. L. Eloranta, and L. Rönnblom. 2011. IFN-a production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1b and LFA-1. J. Immunol. 186: 5085-5094.
16. Cannons, J. L., S. G. Tangye, and P. L. Schwartzberg. 2011. SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 29: 665-705.
17. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91: 10168-10172.
18. Hogarth, M. B., J. H. Slingsby, P. J. Allen, E. M. Thompson, P. Chandler, K. A. Davies, E. Simpson, B. J. Morley, and M. J. Walport. 1998. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J. Immunol. 161: 2753-2761.
19. Tsao, B. P., R. M. Cantor, K. C. Kalunian, C. J. Chen, H. Badsha, R. Singh, D. J. Wallace, R. C. Kitridou, S. L. Chen, N. Shen, et al. 1997. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J. Clin. Invest. 99: 725-731.
20. Moser, K. L., B. R. Neas, J. E. Salmon, H. Yu, C. Gray-McGuire, N. Asundi, G. R. Bruner, J. Fox, J. Kelly, S. Henshall, et al. 1998. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl. Acad. Sci. USA 95: 14869-14874.
21. Cunninghame Graham, D. S., T. J. Vyse, P. R. Fortin, A. Montpetit, Y. C. Cai, S. Lim, T. McKenzie, L. Farwell, B. Rhodes, L. Chad, et al; CaNIOS GenES Investigators. 2008. Association of LY9 in UK and Canadian SLE families. Genes Immun. 9: 93-102.
22. Bombardier, C., D. D. Gladman, M. B. Urowitz, D. Caron, and C. H. Chang; The Committee on Prognosis Studies in SLE. 1992. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum. 35: 630-640.
23. Weber, G., S. Trowitzsch, B. Kastner, R. Lührmann, and M. C. Wahl. 2010. Functional organization of the Sm core in the crystal structure of human U1 snRNP. EMBO J. 29: 4172-4184.
24. Cederblad, B., S. Blomberg, H. Vallin, A. Perers, G. V. Alm, and L. Rönnblom. 1998. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J. Autoimmun. 11: 465-470.
25. Ghirelli, C., R. Zollinger, and V. Soumelis. 2010. Systematic cytokine receptor profiling reveals GM-CSF as a novel TLR-independent activator of human plasmacytoid predendritic cells. Blood 115: 5037-5040.
26. Dzionek, A., Y. Sohma, J. Nagafune, M. Cella, M. Colonna, F. Facchetti, G. Günther, I. Johnston, A. Lanzavecchia, T. Nagasaka, et al. 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194: 1823-1834.
27. Veillette, A. 2010. SLAM-family receptors: immune regulators with or without SAP-family adaptors. Cold Spring Harb. Perspect. Biol. 2: a002469.
28. Kim, J. R., S. O. Mathew, R. K. Patel, R. M. Pertusi, and P. A. Mathew. 2010. Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 160: 348-358.
29. Chatterjee, M., K. Kis-Toth, T. H. Thai, C. Terhorst, and G. C. Tsokos. 2011. SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells. Autoimmunity 44: 211-218.
30. Chatterjee, M., T. Rauen, K. Kis-Toth, V. C. Kyttaris, C. M. Hedrich, C. Terhorst, and G. C. Tsokos. 2012. Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation. J. Immunol. 188: 1206-1212.
31. Schuster, P., N. Donhauser, K. Pritschet, M. Ries, S. Haupt, N. A. Kittan, K. Korn, and B. Schmidt. 2010. Co-ordinated regulation of plasmacytoid dendritic cell surface receptors upon stimulation with herpes simplex virus type 1. Immunology 129: 234-247.
32. Fehniger, T. A., M. H. Shah, M. J. Turner, J. B. VanDeusen, S. P. Whitman, M. A. Cooper, K. Suzuki, M. Wechser, F. Goodsaid, and M. A. Caligiuri. 1999. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162: 4511-4520.
33. Båve, U., M. Magnusson, M. L. Eloranta, A. Perers, G. V. Alm, and L. Rönnblom. 2003. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171: 3296-3302.
34. Means, T. K., E. Latz, F. Hayashi, M. R. Murali, D. T. Golenbock, and A. D. Luster. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115: 407-417.
35. Bouchon, A., M. Cella, H. L. Grierson, J. I. Cohen, and M. Colonna. 2001. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J. Immunol. 167: 5517-5521.
36. Dong, Z., M. E. Cruz-Munoz, M. C. Zhong, R. Chen, S. Latour, and A. Veillette. 2009. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat. Immunol. 10: 973-980.
37. Lee, J. K., S. O. Mathew, S. V. Vaidya, P. R. Kumaresan, and P. A. Mathew. 2007. CS1 (CRACC, CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes. J. Immunol. 179: 4672-4678.
38. Tassi, I., and M. Colonna. 2005. The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase Cgamma signaling pathways in human NK cells. J. Immunol. 175: 7996-8002.
39. Cruz-Munoz, M. E., Z. Dong, X. Shi, S. Zhang, and A. Veillette. 2009. Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function. Nat. Immunol. 10: 297-305.
40. Kim, J. R., N. C. Horton, S. O. Mathew, and P. A. Mathew. 2013. CS1 (SLAMF7) inhibits production of proinflammatory cytokines by activated monocytes. Inflamm. Res. 62: 765-772.
41. Dong, Z., D. Davidson, L. A. Pérez-Quintero, T. Kurosaki, W. Swat, and A. Veillette. 2012. The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells. Immunity 36: 974-985.
42. Blomberg, S., M. L. Eloranta, B. Cederblad, K. Nordlin, G. V. Alm, and L. Rönnblom. 2001. Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus 10: 484-490.
43. Tucci, M., C. Quatraro, L. Lombardi, C. Pellegrino, F. Dammacco, and F. Silvestris. 2008. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 58: 251-262.
44. Hoffman, T. 1980. Natural killer function in systemic lupus erythematosus. Arthritis Rheum. 23: 30-35.
45. Hervier, B., V. Beziat, J. Haroche, A. Mathian, P. Lebon, P. Ghillani-Dalbin, L. Musset, P. Debré, Z. Amoura, and V. Vieillard. 2011. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-g production in patients with active disease. Arthritis Rheum. 63: 1698-1706.
46. Rönnblom, L., and K. B. Elkon. 2010. Cytokines as therapeutic targets in SLE. Nat. Rev. Rheumatol. 6: 339-347.